Vertex Pharmaceuticals

Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. The company transformed the treatment of cystic fibrosis by developing therapies that target the underlying genetic cause of the disease, including Trikafta, alongside commercializing CRISPR-based gene-editing therapy Casgevy. Through specialized small-molecule chemistry and genetic therapies, Vertex Pharmaceuticals tackles severe diseases with high unmet need.